BioNTech SE ADR (NASDAQ:BNTX) has a beta value of 0.24 and has seen 1.06 million shares traded in the recent trading session. The company, currently valued at $23.85B, closed the recent trade at $100.33 per share which meant it gained $8.26 on the day or 8.97% during that session. The BNTX stock price is -25.42% off its 52-week high price of $125.83 and 15.07% above the 52-week low of $85.21. The 3-month trading volume is 594.02K shares.
BioNTech SE ADR (NASDAQ:BNTX) trade information
Sporting 8.97% in the green today, the stock has traded in the green over the last five days, when the BNTX stock price touched $100.33 or saw a fall of -1.67%. Year-to-date, BioNTech SE ADR shares have moved -4.94%, while the 5-day performance has seen it change 8.82%. Over the past 30 days, the shares of BioNTech SE ADR (NASDAQ:BNTX) have changed 13.38%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BioNTech SE ADR (BNTX) estimates and forecasts
Figures show that BioNTech SE ADR shares have underperformed across the wider relevant industry. The company’s shares have gained 1.52% over the past 6 months, with this year growth rate of -147.95%, compared to 15.20% for the industry. Revenue growth from the last financial year stood is estimated to be -28.80%.
8 analysts offering their estimates for the company have set an average revenue estimate of 175.55M for the current quarter. 8 have an estimated revenue figure of 732.42M for the next ending quarter.
BNTX Dividends
BioNTech SE ADR is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
